Takeda and Shire shareholders approve acquisition, clearing the way for a near-term closing: https://www.wsj.com/articles/takeda-wins-shareholder-approval-for-its-62-billion-shire-bid-1543982265 The combined company will be a top-10 Big Pharma with annual revenue of about $30B.